Literature DB >> 22380596

Assessment of a rule-based virtual screening technology (INDDEx) on a benchmark data set.

Christopher R Reynolds1, Ata C Amini, Stephen H Muggleton, Michael J E Sternberg.   

Abstract

The Investigational Novel Drug Discovery by Example (INDDEx) package has been developed to find active compounds by linking activity to chemical substructure and to guide the process of further drug development. INDDEx is a machine-learning technique, based on forming qualitative logical rules about substructural features of active molecules, weighting the rules to form a quantitative model, and then using the model to screen a molecular database. INDDEx is shown to be able to learn from multiple active compounds and to be useful for scaffold-hopping when performing virtual screening, giving high retrieval rates even when learning from a small number of compounds. Across the data sets tested, at 1% of the data, INDDEx was found to have average enrichment factors of 69.2, 82.7, and 90.4 when learning from 2, 4, and 8 active ligands, respectively. At 0.1% of the data, INDDEx had average enrichment factors of 492, 631, and 707 when learning from 2, 4, and 8 active ligands, respectively. Excluding all ligands with more than 0.5 Tanimoto Maximum Common Substructure, INDDEx had average enrichment factors at 1% of 52.3, 63.6, and 66.9 when learning from 2, 4, and 8 active ligands, respectively. The performance of INDDEx is compared with that of eHiTS LASSO, PharmaGist, and DOCK.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22380596     DOI: 10.1021/jp212084f

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  2 in total

1.  GCAC: galaxy workflow system for predictive model building for virtual screening.

Authors:  Deepak R Bharti; Anmol J Hemrom; Andrew M Lynn
Journal:  BMC Bioinformatics       Date:  2019-02-04       Impact factor: 3.169

2.  Incorporating Virtual Reactions into a Logic-based Ligand-based Virtual Screening Method to Discover New Leads.

Authors:  Christopher R Reynolds; Stephen H Muggleton; Michael J E Sternberg
Journal:  Mol Inform       Date:  2015-03-20       Impact factor: 3.353

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.